The hsa_circ_0084050/miR-373-3p Axis Controls Bone Sialoprotein-Induced ADAM9 Upregulation to Drive Lung Cancer Progression and Metastasis
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27177840 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Le Huynh Hoai Thuong und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, School of Medicine, China Medical University, Taichung 404, Taiwan. Hauptthemen laut MEDLINE: Lung Neoplasms, ADAM Proteins, MicroRNAs, Membrane Proteins. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science and Technology Council, China Medical University.
Abstract (Originalsprache)
Lung cancer carries a high mortality burden, with metastatic dissemination accounting for much of its poor prognosis. Bone sialoprotein (BSP), a matricellular protein belonging to the SIBLING family, has been associated with tumor invasion; nonetheless, its role in lung cancer remains inadequately characterized. Clinical database analysis indicates that BSP is the most critical SIBLING protein associated with lung cancer proliferation and metastasis. Our clinical data also confirmed that BSP levels are higher in metastatic lung cancer compared to non-metastatic cases. We further demonstrate that BSP promotes lung cancer progression and motility through upregulated ADAM9 expression. Mechanistically, we revealed that BSP enhances ADAM9-dependent proliferation and motility via the FAK pathway. In addition, the hsa_circ_0084050/miR-373-3p regulatory axis contributes to BSP-mediated ADAM9 regulation. In an exploratory mouse metastasis model established by caudal artery injection of A549 control or stable BSP-shRNA cells into male BALB/c nude mice, BSP knockdown was associated with a lower metastatic tumor burden. Therefore, BSP may serve as a therapeutic target for limiting lung cancer progression and metastatic dissemination.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, School of Medicine, China Medical University, Taichung 404, Taiwan.
- Division of General Thoracic Surgery, Department of Surgery, Changhua Christian Hospital, Changhua 500, Taiwan.
- Department of Neurosurgery, China Medical University Hospital, Taichung 404, Taiwan.
- Department of Physical Therapy, Asia University, Taichung 404, Taiwan.
- Department of General Thoracic Surgery, Asia University Hospital, Taichung 404, Taiwan.
- Chinese Medicine Research Center, China Medical University, Taichung 404, Taiwan.
ORCID-Profile: Le Huynh Hoai Thuong, Chang-Lun Huang, Po-I Liu, Chih-Hsin Tang
Förderung
- National Science and Technology Council
- China Medical University
Zitieren
APA
Huynh Hoai Thuong, L., Huang, C. L., Liu, C. L., Guo, J. H., Liu, P. I., & Tang, C. H. (2026). The hsa_circ_0084050/miR-373-3p Axis Controls Bone Sialoprotein-Induced ADAM9 Upregulation to Drive Lung Cancer Progression and Metastasis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27177840
Vancouver
Huynh Hoai Thuong L, Huang CL, Liu CL, Guo JH, Liu PI, Tang CH. The hsa_circ_0084050/miR-373-3p Axis Controls Bone Sialoprotein-Induced ADAM9 Upregulation to Drive Lung Cancer Progression and Metastasis. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27177840
BibTeX
@article{HuynhHoaiThuong2026,
author = {Huynh Hoai Thuong, Le and Huang, Chang-Lun and Liu, Chun-Lin and Guo, Jeng-Hung and Liu, Po-I and Tang, Chih-Hsin},
title = {The hsa_circ_0084050/miR-373-3p Axis Controls Bone Sialoprotein-Induced ADAM9 Upregulation to Drive Lung Cancer Progression and Metastasis},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27177840}
}
EUVIMED